Enhancement of Ketone Supplements-Evoked Effect on Absence Epileptic Activity by Co-Administration of Uridine in Wistar Albino Glaxo Rijswijk Rats

Enhancement of Ketone Supplements-Evoked Effect on Absence Epileptic Activity by Co-Administration of Uridine in Wistar Albino Glaxo Rijswijk Rats

Both uridine and exogenous ketone supplements decreased the number of spike-wave discharges (SWDs) in a rat model of human absence epilepsy Wistar Albino Glaxo/Rijswijk (WAG/Rij) rats. It has been suggested that alleviating influence of both uridine and ketone supplements on absence epileptic activi...

Full description

Bibliographic Details
Main Authors:	Brigitta Brunner, Enikő Rauch, Csilla Ari, Dominic P. D’Agostino, Zsolt Kovács
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Nutrients
Subjects:	exogenous ketone supplement uridine adenosine receptors absence epilepsy
Online Access:	https://www.mdpi.com/2072-6643/13/1/234

Similar Items

Anxiolytic Effect of Exogenous Ketone Supplementation Is Abolished by Adenosine A1 Receptor Inhibition in Wistar Albino Glaxo/Rijswijk Rats
by: Zsolt Kovács, et al.
Published: (2018-02-01)

Inhibition of adenosine A1 receptors abolished the nutritional ketosis-evoked delay in the onset of isoflurane-induced anesthesia in Wistar Albino Glaxo Rijswijk rats
by: Zsolt Kovács, et al.
Published: (2020-01-01)

Exogenous Ketone Supplementation Decreased the Lipopolysaccharide-Induced Increase in Absence Epileptic Activity in Wistar Albino Glaxo Rijswijk Rats
by: Zsolt Kovács, et al.
Published: (2019-02-01)

Age- and Sex-Dependent Modulation of Exogenous Ketone Supplement-Evoked Effects on Blood Glucose and Ketone Body Levels in Wistar Albino Glaxo Rijswijk Rats
by: Zsolt Kovács, et al.
Published: (2021-01-01)

Exogenous ketone supplements reduce anxiety-related behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk rats
by: Csilla Ari, et al.
Published: (2016-12-01)

Adenosine A1 Receptor Antagonism Abolished the Anti-seizure Effects of Exogenous Ketone Supplementation in Wistar Albino Glaxo Rijswijk Rats
by: Zsolt Kovács, et al.
Published: (2017-07-01)

Ketone supplementation abolished isoflurane anesthesia-induced elevation in blood glucose level and increased recovery time from anesthesia in Wistar Albino Glaxo Rijswijk rats
by: Zsolt Kovács, et al.
Published: (2023-02-01)

Adenosine Receptors Modulate the Exogenous Ketogenic Supplement-Evoked Alleviating Effect on Lipopolysaccharide-Generated Increase in Absence Epileptic Activity in WAG/Rij Rats
by: Brigitta Brunner, et al.
Published: (2021-11-01)

Uridine release during aminopyridine-induced epilepsy
by: A Slézia, et al.
Published: (2004-08-01)

Ketone Supplementation: Meeting the Needs of the Brain in an Energy Crisis
by: Angela M. Poff, et al.
Published: (2021-12-01)

Dose-Dependent Beneficial Effect of Ketone Supplement-Evoked Ketosis on Anxiety Level in Female WAG/Rij Rats: Sometimes Less Is More
by: Enikő Rauch, et al.
Published: (2023-10-01)

Exogenous Ketones Lower Blood Glucose Level in Rested and Exercised Rodent Models
by: Csilla Ari, et al.
Published: (2019-10-01)

Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature
by: Zsolt Kovács, et al.
Published: (2019-05-01)

Ketone Administration for Seizure Disorders: History and Rationale for Ketone Esters and Metabolic Alternatives
by: Angela M. Poff, et al.
Published: (2019-10-01)

Editorial: Emerging aspects of ketone metabolism in health & disease
by: Brianna Jane Stubbs, et al.
Published: (2024-04-01)

Protocol for UVC uridine actinometry
by: Dana Pousty, et al.
Published: (2023-01-01)

On the Metabolism of Exogenous Ketones in Humans
by: Brianna J. Stubbs, et al.
Published: (2017-10-01)

Uridine monophosphate (UMP)-responsive developmental and epileptic encephalopathy: A case report of two siblings and a review of literature
by: Ali Al-Otaibi, et al.
Published: (2022-03-01)

Ketone bodies for kidney injury and disease
by: Pedro Rojas-Morales, et al.
Published: (2021-07-01)

Case Report: Rapid Treatment of Uridine-Responsive Epileptic Encephalopathy Caused by CAD Deficiency
by: Ling Zhou, et al.
Published: (2020-12-01)

A randomized, open-label, parallel pilot study investigating metabolic product kinetics of the novel ketone ester, bis-hexanoyl (R)-1,3-butanediol, over one week of ingestion in healthy adults
by: Eunice Mah, et al.
Published: (2023-06-01)

Exogenous Ketones and Lactate as a Potential Therapeutic Intervention for Brain Injury and Neurodegenerative Conditions
by: Naomi Elyse Omori, et al.
Published: (2022-04-01)

A systematic review and meta-regression of exogenous ketone infusion rates and resulting ketosis—A tool for clinicians and researchers
by: Kristi L. Storoschuk, et al.
Published: (2023-06-01)

Effect of uridine protecting groups on the diastereoselectivity of uridine-derived aldehyde 5’-alkynylation
by: Raja Ben Othman, et al.
Published: (2017-08-01)

Ketone Ester Supplementation Improves Some Aspects of Cognitive Function during a Simulated Soccer Match after Induced Mental Fatigue
by: Manuel D. Quinones, et al.
Published: (2022-10-01)

Synthesis and Preliminary Biological Evaluations of 5′-Substituted Derivatives of Uridine as Glycosyltransferase Inhibitors
by: Ilona Wandzik, et al.
Published: (2013-07-01)

Novel CAD gene mutations in a boy with developmental and epileptic encephalopathy 50 with dramatic response to uridine therapy: a case report and a review of the literature
by: Lifen Duan, et al.
Published: (2024-03-01)

A Patient With CAD Deficiency Responsive to Uridine and Literature Review
by: Ling Zhou, et al.
Published: (2020-02-01)

Exogenous Ketone Supplements Improved Motor Performance in Preclinical Rodent Models
by: Csilla Ari, et al.
Published: (2020-08-01)

Indispensable residue for uridine binding in the uridine-cytidine kinase family
by: Fumiaki Tomoike, et al.
Published: (2017-09-01)

Ketone Monoester Followed by Carbohydrate Ingestion after Glycogen-Lowering Exercise Does Not Improve Subsequent Endurance Cycle Time Trial Performance
by: Manuel D. Quinones, et al.
Published: (2024-03-01)

Uridine as a novel fuel for cancer cells
by: Ruby Dhar, et al.
Published: (2023-07-01)

SYNTHESIS A NUMBER OF URIDINE DERIVATIVES AND STUDYING THEIR BIOLOGICAL ACTIVITY ON PATHOGENIC BACTERIA.
by: YOUSIF HINDY KHALAF, et al.
Published: (2012-06-01)

Commentary: Ketone Diester Ingestion Impairs Time-Trial Performance in Professional Cyclists
by: Brianna J. Stubbs, et al.
Published: (2018-03-01)

Ingested Ketone Ester Leads to a Rapid Rise of Acetyl-CoA and Competes with Glucose Metabolism in the Brain of Non-Fasted Mice
by: Laurent Suissa, et al.
Published: (2021-01-01)

Tolerability and Safety of a Novel Ketogenic Ester, Bis-Hexanoyl (R)-1,3-Butanediol: A Randomized Controlled Trial in Healthy Adults
by: Oliver Chen, et al.
Published: (2021-06-01)

The Effects of a 6-Week Controlled, Hypocaloric Ketogenic Diet, With and Without Exogenous Ketone Salts, on Body Composition Responses
by: Alex Buga, et al.
Published: (2021-03-01)

Comparison of Ketogenic Diets with and without Ketone Salts versus a Low-Fat Diet: Liver Fat Responses in Overweight Adults
by: Christopher D. Crabtree, et al.
Published: (2021-03-01)

Uridine Inhibits Hepatocellular Carcinoma Cell Development by Inducing Ferroptosis
by: Liuliu Zi, et al.
Published: (2023-05-01)

Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction
by: Isabelle Adant, et al.
Published: (2022-09-01)